Literature DB >> 81925

Protective effect of propranolol in threatened myocardial infarction.

R M Norris, E D Clarke, N L Sammel, W M Smith, B Williams.   

Abstract

Propranolol 0.1 mg/kg intravenously followed by 320 mg orally over 27 h was given to 20 randomly selected patients within 4 h of the onset of suspected myocardial infarction unaccompanied by diagnostic electrocardiographic changes. Patients given propranolol had fewer completed infarcts as assessed by serial electrocardiograms, a lower frequency of serum-creatine-kinase levels above the normal range, and lower peak serum-creatine-kinase levels than 23 control subjects. This evidence suggests that threatened myocardial infarction can in some cases be prevented by early beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81925     DOI: 10.1016/s0140-6736(78)91628-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

Review 1.  According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction?

Authors:  J K Kjekshus
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

2.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

Authors:  Saurav Chatterjee; Debanik Chaudhuri; Rajesh Vedanthan; Valentin Fuster; Borja Ibanez; Sripal Bangalore; Debabrata Mukherjee
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

3.  Percutaneous transluminal coronary angioplasty of one vessel for refractory unstable angina pectoris: efficacy in single and multivessel disease.

Authors:  B Sharma; R P Wyeth; G S Kolath; H J Gimenez; J A Franciosa
Journal:  Br Heart J       Date:  1988-03

4.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

5.  Intravenous beta-blockers during unstable angina and threatened infarction.

Authors:  R M Norris; P F Barnaby; G G Geary
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 6.  "But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk.

Authors:  J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

Review 7.  Beta-adrenoceptor blockers. An update on their role in acute myocardial infarction.

Authors:  R M Norris
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

8.  Initiation and maintenance of beta-blockade with intravenous oxprenolol.

Authors:  B Silke; V A John; R T Calvert; S H Taylor
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

Authors:  R Lochan; B Silke; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

10.  Advantages of technetium pyrophosphate scintigraphy over plasma enzyme analysis in estimation of anterior myocardial infarct size.

Authors:  S Saltissi; P S Robinson; M M Webb-Peploe; D J Coltart; D N Croft
Journal:  Br Heart J       Date:  1981-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.